DigiNepal Health ENनेहि

← स्वास्थ्य · दवाएँ

Beractant

Surfactant

WHO आवश्यक दवा EML अनुभाग: Medicines administered to the neonate

यह केवल जानकारी है, प्रिस्क्रिप्शन नहीं। कोई भी दवा लेने से पहले डॉक्टर या फार्मासिस्ट से सलाह लें। ओवरडोज़/विषाक्तता पर 102 पर कॉल करें।

ब्रांड नाम

Nepal brand names not included: no licence-safe source.

What it is used for

SURVANTA is indicated for prevention and treatment (“rescue”) of Respiratory Distress Syndrome (RDS) (hyaline membrane disease) in premature infants.

Common side effects

The occurrence of concurrent illnesses common in premature infants was evaluated in the controlled trials. The rates in all controlled studies are in Table 3. Table 3.

Do not use if (contraindications)

None

ओवरडोज़ या विषाक्तता

ओवरडोज़/विषाक्तता की आशंका पर अभी 102 पर कॉल करें।

102

सामान्य प्रश्न

What is Beractant used for?
SURVANTA is indicated for prevention and treatment (“rescue”) of Respiratory Distress Syndrome (RDS) (hyaline membrane disease) in premature infants.

What are the side effects of Beractant?
The occurrence of concurrent illnesses common in premature infants was evaluated in the controlled trials. The rates in all controlled studies are in Table 3. Table 3.

Who should not take Beractant?
None

What is the dose of Beractant?
Not provided here. Ask a doctor or pharmacist.

Beractant क्या है?
Beractant is used for: SURVANTA is indicated for prevention and treatment (“rescue”) of Respiratory Distress Syndrome (RDS) (hyaline membrane disease) in premature infants. It belongs to the class: Surfactant. Common side effects include: The occurrence of concurrent illnesses common in premature infants was evaluat…

Beractant के दुष्प्रभाव क्या हैं?
The occurrence of concurrent illnesses common in premature infants was evaluated in the controlled trials. The rates in all controlled studies are in Table 3. Table 3.

स्रोत: FDA SPL label (openFDA/DailyMed); RxNorm (NLM) · Reference · Reference · Reference

US FDA DailyMed; NLM RxNorm

आपात — कॉल102